INS and liver dysplastic nodule: Patients in cluster 3 (who are most resistant to insulin) have a significantly higher risk of DN than those in groups 4 and 5, despite they receive similar diabetes treatment.[121] Precise stratification to identify individuals with increased risk of complications at diagnosis could provide a powerful tool for individualized treatment planning.